{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T16:50:34Z","timestamp":1778172634593,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2013,9,19]],"date-time":"2013-09-19T00:00:00Z","timestamp":1379548800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1007\/s00417-013-2467-4","type":"journal-article","created":{"date-parts":[[2013,9,18]],"date-time":"2013-09-18T07:38:38Z","timestamp":1379489918000},"page":"2555-2561","source":"Crossref","is-referenced-by-count":19,"title":["Inhibitory effects of topical cyclosporine A 0.05\u00a0% on immune-mediated corneal neovascularization in rabbits"],"prefix":"10.1007","volume":"251","author":[{"given":"Yasin Y\u00fccel","family":"Bucak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mesut","family":"Erdurmus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u00e7in Hakan","family":"Terzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aysel","family":"K\u00fckner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serdal","family":"\u00c7elebi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,9,19]]},"reference":[{"key":"2467_CR1","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1097\/ICO.0b013e31823cc098","volume":"31","author":"P Prabhasawat","year":"2012","unstructured":"Prabhasawat P, Tesavibul N, Mahawong W (2012) A randomized double-masked study of 0.05% cyclosporine ophthalmic emulsion in the treatment of meibomian gland dysfunction. Cornea 31:1386\u20139133","journal-title":"Cornea"},{"key":"2467_CR2","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s12325-009-0037-2","volume":"26","author":"BA Schechter","year":"2009","unstructured":"Schechter BA, Katz RS, Friedman LS (2009) Efficacy of topical cyclosporine for the treatment of ocular rosacea. Adv Ther 26:651\u2013659","journal-title":"Adv Ther"},{"key":"2467_CR3","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jcrs.2005.10.034","volume":"32","author":"GM Salib","year":"2006","unstructured":"Salib GM, McDonald MB, Smolek M (2006) Safety and efficacy of cyclosporine 0.05% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusis. J Cataract Refract Surg 32:772\u2013728","journal-title":"J Cataract Refract Surg"},{"key":"2467_CR4","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0161-6420(98)99043-1","volume":"105","author":"M Hingorani","year":"1998","unstructured":"Hingorani M, Moodaley L, Calder VL, Buckley RJ, Lightman S (1998) A randomized, placebo-controlled trial of topical cyclosporin A in steroid-dependent atopic keratoconjunctivitis. Ophthalmology 105:1715\u20131720","journal-title":"Ophthalmology"},{"key":"2467_CR5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1442-9071.2008.01784.x","volume":"36","author":"A Poon","year":"2008","unstructured":"Poon A, Constantinou M, Lamoureux E, Taylor HR (2008) Topical Cyclosporin A in the treatment of acute graft rejection: a randomized controlled trial. Clin Exp Ophthalmol 36:415\u2013421","journal-title":"Clin Exp Ophthalmol"},{"key":"2467_CR6","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/01.ico.0000208813.17367.0c","volume":"25","author":"SN Rao","year":"2006","unstructured":"Rao SN, Rao RD (2006) Efficacy of topical cyclosporine 0.05% in the treatment of dry eye associated with graft versus host disease. Cornea 25:674\u2013678","journal-title":"Cornea"},{"key":"2467_CR7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1471-2415-12-42","volume":"12","author":"S Okumus","year":"2012","unstructured":"Okumus S, Coskun E, Tatar MG, Kaydu E, Yayuspayi R, Comez A, Erbagci I, Gurler B (2012) Cyclosporine a 0.05% eye drops for the treatment of subepithelial infiltrates after epidemic keratoconjunctivitis. BMC Ophthalmol 12:42","journal-title":"BMC Ophthalmol"},{"key":"2467_CR8","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/01.tp.0000285489.91595.13","volume":"84","author":"KA Williams","year":"2007","unstructured":"Williams KA, Coster DJ (2007) The immunobiology of corneal transplantation. Transplantation 84:806\u2013813","journal-title":"Transplantation"},{"key":"2467_CR9","first-page":"624","volume":"18","author":"Y Liu","year":"2012","unstructured":"Liu Y, Jiang J, Xiao H, Wang X, Li Y, Gong Y, Wang D, Huang Y (2012) Topical application of FTY720 and cyclosporin A prolong corneal graft survival in mice. Mol Vis 18:624\u2013633","journal-title":"Mol Vis"},{"key":"2467_CR10","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1084\/jem.193.5.607","volume":"193","author":"GL Hern\u00e1ndez","year":"2001","unstructured":"Hern\u00e1ndez GL, Volpert OV, I\u00f1iguez MA, Lorenzo E, Mart\u00ednez-Mart\u00ednez S, Grau R, Fresno M, Redondo JM (2001) Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2. J Exp Med 193:607\u2013620","journal-title":"J Exp Med"},{"key":"2467_CR11","first-page":"274","volume":"38","author":"U Benelli","year":"1997","unstructured":"Benelli U, Ross JR, Nardi M, Klintworth GK (1997) Corneal neovascularization induced by xenografts or chemical cautery. Inhibition by cyclosporin A. Invest Ophthalmol Vis Sci 38:274\u2013282","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2467_CR12","doi-asserted-by":"crossref","first-page":"5991","DOI":"10.1128\/IAI.68.10.5991-5997.2000","volume":"68","author":"N Saita","year":"2000","unstructured":"Saita N, Fujiwara N, Yano I, Soejima K, Kobayashi K (2000) Trehalose 6,6\u2032-dimycolate (cord factor) of Mycobacterium tuberculosis induces corneal angiogenesis in rats. Infect Immun 68:5991\u20135997","journal-title":"Infect Immun"},{"key":"2467_CR13","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10456-011-9223-3","volume":"14","author":"BB Peebo","year":"2011","unstructured":"Peebo BB, Fagerholm P, Traneus-R\u00f6ckert C, Lagali N (2011) Cellular level characterization of capillary regression in inflammatory angiogenesis using an in vivo corneal model. Angiogenesis 14:393\u2013405","journal-title":"Angiogenesis"},{"key":"2467_CR14","first-page":"2514","volume":"41","author":"W Philipp","year":"2000","unstructured":"Philipp W, Speicher L, Humpel C (2000) Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas. Invest Ophthalmol Vis Sci 41:2514\u20132522","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2467_CR15","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","volume":"12","author":"JH Chang","year":"2001","unstructured":"Chang JH, Gabison EE, Kato T, Azar DT (2001) Corneal neovascularization. Curr Opin Ophthalmol 12:242\u2013249","journal-title":"Curr Opin Ophthalmol"},{"key":"2467_CR16","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00003226-198706040-00004","volume":"6","author":"RJ Epstein","year":"1987","unstructured":"Epstein RJ, Stulting RD, Hendricks RL, Harris DM (1987) Corneal neovascularization: pathogenesis and inhibition. Cornea 6:250\u2013257","journal-title":"Cornea"},{"key":"2467_CR17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0039-6257(98)00035-6","volume":"43","author":"P Lee","year":"1998","unstructured":"Lee P, Wang CC, Adamis AP (1998) Ocular neovascularization: an epidemiologic review. Surv Ophthalmol 43:245\u2013269","journal-title":"Surv Ophthalmol"},{"key":"2467_CR18","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/ICO.0b013e31804f5a45","volume":"26","author":"M Erdurmus","year":"2007","unstructured":"Erdurmus M, Yagci R, Yilmaz B, Hepsen IF, Turkmen C, Aydin B, Karadag R (2007) Inhibitory effects of topical thymoquinone on corneal neovascularization. Cornea 26:715\u2013719","journal-title":"Cornea"},{"key":"2467_CR19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3181\/00379727-74-17822","volume":"74","author":"IS Jones","year":"1950","unstructured":"Jones IS, Meyer K (1950) Inhibition of vascularization of the rabbit cornea by local application of cotisone. Proc Soc Exp Biol Med 74:102\u2013104","journal-title":"Proc Soc Exp Biol Med"},{"key":"2467_CR20","doi-asserted-by":"crossref","first-page":"362","DOI":"10.4065\/74.4.362","volume":"74","author":"KH Baratz","year":"1999","unstructured":"Baratz KH, Hattenhauer MG (1999) Indiscriminate use of corticosteroid-containing eyedrops. Mayo Clin Proc 74:362\u2013366","journal-title":"Mayo Clin Proc"},{"key":"2467_CR21","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00417-007-0587-4","volume":"245","author":"M Erdurmus","year":"2007","unstructured":"Erdurmus M, Totan Y (2007) Subconjunctival bevacizumab for corneal neovascularization. Graefes Arch Clin Exp Ophthalmol 245:1577\u20131579","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2467_CR22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00417-007-0684-4","volume":"246","author":"F Bock","year":"2008","unstructured":"Bock F, K\u00f6nig Y, Kruse F, Baier M, Cursiefen C (2008) Bevacizumab (Avastin) eye drops inhibit corneal neovascularization. Graefes Arch Clin Exp Ophthalmol 246:281\u2013284","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2467_CR23","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/bjophthalmol-2012-302137","volume":"97","author":"C Petsoglou","year":"2013","unstructured":"Petsoglou C, Balaggan KS, Dart JK, Bunce C, Xing W, Ali RR, Tuft SJ (2013) Subconjunctival bevacizumab induces regression of corneal neovascularisation: a pilot randomised placebo-controlled double-masked trial. Br J Ophthalmol 97:28\u201332","journal-title":"Br J Ophthalmol"},{"key":"2467_CR24","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/archophthalmol.2009.18","volume":"127","author":"MH Dastjerdi","year":"2009","unstructured":"Dastjerdi MH, Al-Arfaj KM, Nallasamy N, Hamrah P, Jurkunas UV, Pineda R 2nd, Pavan-Langston D, Dana R (2009) Topical bevacizumab in the treatment of corneal neovascularization: results of a prospective, open-label, noncomparative study. Arch Ophthalmol 127:381\u2013389","journal-title":"Arch Ophthalmol"},{"key":"2467_CR25","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00417-009-1099-1","volume":"247","author":"Y Koenig","year":"2009","unstructured":"Koenig Y, Bock F, Horn F, Kruse F, Straub K, Cursiefen C (2009) Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin) eye drops against corneal neovascularization. Graefes Arch Clin Exp Ophthalmol 247:1375\u20131382","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2467_CR26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1167\/iovs.01-1277","volume":"44","author":"AM Joussen","year":"2003","unstructured":"Joussen AM, Poulaki V, Mitsiades N, Stechschulte SU, Kirchhof B, Dartt DA, Fong GH, Rudge J (2003) VEGF-dependent conjunctivalization of the corneal surface. Invest Ophthalmol Vis Sci 44:117\u2013123","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2467_CR27","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s00347-007-1512-2","volume":"104","author":"F Bock","year":"2007","unstructured":"Bock F, Konig Y, Dietrich T, Zimmermann P, Baier M, Cursiefen C (2007) Inhibition of angiogenesis in the anterior chamber of the eye [in German]. Ophthalmologe 104:336\u2013344","journal-title":"Ophthalmologe"},{"key":"2467_CR28","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/s00417-002-0496-5","volume":"240","author":"M K\u00fcchle","year":"2002","unstructured":"K\u00fcchle M, Cursiefen C, Nguyen NX, Langenbucher A, Seitz B, Wenkel H, Martus P, Naumann GO (2002) Risk factors for corneal allograft rejection: intermediate results of a prospective normal-risk keratoplasty study. Graefes Arch Clin Exp Ophthalmol 240:580\u2013584","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2467_CR29","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00417-006-0410-7","volume":"245","author":"P Maier","year":"2007","unstructured":"Maier P, Bohringer D, Reinhard T (2007) Clear graft survival and immune reactions following emergency keratoplasty. Graefes Arch Clin Exp Ophthalmol 245:351\u2013359","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2467_CR30","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0161-6420(94)31138-9","volume":"101","author":"MG Maguire","year":"1994","unstructured":"Maguire MG, Stark WJ, Gottsch JD, Stulting RD, Sugar A, Fink NE, Schwartz A (1994) Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Collaborative corneal transplantation studies research group. Ophthalmology 101:1536\u20131547","journal-title":"Ophthalmology"},{"key":"2467_CR31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ajo.2011.01.019","volume":"152","author":"J Shimazaki","year":"2011","unstructured":"Shimazaki J, Den S, Omoto M, Satake Y, Shimmura S, Tsubota K (2011) Prospective, randomized study of the efficacy of systemic cyclosporine in high-risk corneal transplantation. Am J Ophthalmol 152:33\u201339.e1","journal-title":"Am J Ophthalmol"},{"key":"2467_CR32","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/ICO.0b013e318201405a","volume":"30","author":"D Gupta","year":"2011","unstructured":"Gupta D, Illingworth C (2011) Treatments for corneal neovascularization: a review. Cornea 30:927\u2013938","journal-title":"Cornea"},{"key":"2467_CR33","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/archopht.1992.01080150103037","volume":"110","author":"RM Lipman","year":"1992","unstructured":"Lipman RM, Epstein RJ, Hendricks RL (1992) Suppression of corneal neovascularization with cyclosporine. Arch Ophthalmol 110:405\u2013407","journal-title":"Arch Ophthalmol"},{"key":"2467_CR34","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/art.10215","volume":"46","author":"ML Cho","year":"2002","unstructured":"Cho ML, Cho CS, Min SY, Kim SH, Lee SS, Kim WU, Min DJ, Min JK, Youn J, Hwang SY, Park SH, Kim HY (2002) Cyclosporine inhibition of vascular endothelial growth factor production in rheumatoid synovial fibroblasts. Arthritis Rheum 46:1202\u20131209","journal-title":"Arthritis Rheum"},{"key":"2467_CR35","doi-asserted-by":"crossref","first-page":"8718","DOI":"10.1167\/iovs.11-7871","volume":"52","author":"MH Dastjerdi","year":"2011","unstructured":"Dastjerdi MH, Sadrai Z, Saban DR, Zhang Q, Dana R (2011) Corneal penetration of topical and subconjunctival bevacizumab. Invest Ophthalmol Vis Sci 52:8718\u20138723","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-013-2467-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-013-2467-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-013-2467-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T22:57:23Z","timestamp":1715986643000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-013-2467-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,19]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["2467"],"URL":"https:\/\/doi.org\/10.1007\/s00417-013-2467-4","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,19]]}}}